Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080616/0/en/Olema-Oncology-Reports-First-Quarter-2025-Financial-and-Operating-Results.html
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078547/0/en/Olema-Oncology-to-Participate-in-Upcoming-Investor-Conferences.html
02 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/02/3073563/0/en/Olema-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
25 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/25/3068514/0/en/Olema-Oncology-Announces-New-Preclinical-Data-for-OP-3136-Demonstrating-Anti-Tumor-Activity-in-Multiple-Solid-Tumor-Models-at-AACR-2025.html
02 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/02/3054722/0/en/Olema-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3049198/0/en/Olema-Oncology-to-Present-Preclinical-Data-for-OP-3136-a-Potent-KAT6-Inhibitor-Demonstrating-Anti-Tumor-Activity-in-Multiple-Solid-Tumor-Models-at-the-2025-AACR-Annual-Meeting.html
ABOUT THIS PAGE